Procurement Summary
Country : Germany
Summary : Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations
Deadline : 03 Jan 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 77466377
Document Ref. No. : 031008-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of this publication is the conclusion of contracts according to Section 130a (8) SGB V for the following active ingredients/active ingredient combinations as part of a so-called open-house procedure:
Epinephrine (C01CA24, R03AA01)
Fusidic acid (D06Ax01)
Lipegfilgrastim (L03AA14)
Macrogol Combinations (A06AD65)
Octreotid (H01CB02)
Pyridostigmine (N07AA02)
TiotropiumConclusion of a discount contract according to § 130a Para. 8 SGB V for the mentioned active ingredients/active ingredient combinations.
The earliest start of the contract is March 1st, 2023. Based on this, the contract period is a maximum of 24 months.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 2023-01-12-NW-DRA-Open House
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-01-12
Publish Date : 2023-01-17
Submission Date : 2025-01-03
Documents
Tender Notice